Even one of the three panelists who voted that there wasn't sufficient proof to tar Avandia with a warning about heart attack risks told the FDA it needed to do a better job getting Avandia data.
We know that those with so-called disabilities don't fall into the pity tar-pit and in fact, do better than they or anyone around them ever thought possible.
The North Carolina Tar Heels won't be defending their title in this month's NCAA tournament, but when it comes to team value they can claim bragging rights for another year.